课题基金 / 基金详情

Treatment of Age Related Macular Degeneration with CD36 Receptor Modulators

Treatment of Age Related Macular Degeneration with CD36 Receptor Modulators
用 CD36 受体调节剂治疗年龄相关性黄斑变性
批准号:
295751
负责人:
Lubell William D
金额:
$39.42万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-10-01 至 2016-10-01

项目摘要

项目成果

Lubell William D的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Age Related Macular Degeneration (AMD) is the leading cause of blindness in Canada. Nearly 80,000 Canadians were estimated to be affected with AMD and as our population ages this number is expected to grow at a rate of 10,000 per year. A common eye condit
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interleukin-1 Receptor Modulating Therapy for Treating Macular Degeneration
  • 批准号:
    478746
  • 项目类别:
    Operating Grants
  • 资助金额:
    $37.62万
  • 财政年份:
    2023
  • 负责人:
    Lubell William D
  • 依托单位:
Treating Age-Related Macular Degeneration by Mitigating Inflammation, Oxidative Stress, and Lipid Accumulation through CD36 Modulation
  • 批准号:
    468104
  • 项目类别:
    Operating Grants
  • 资助金额:
    $60.75万
  • 财政年份:
    2022
  • 负责人:
    Lubell William D
  • 依托单位:
Safe and selective anti-parasite therapy targeting ribosome and glycosome function
  • 批准号:
    451337
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.65万
  • 财政年份:
    2021
  • 负责人:
    Lubell William D
  • 依托单位:
Allosteric Modulation of the Urotensin Receptor with Small-Molecule Peptide Mimics
  • 批准号:
    407925
  • 项目类别:
    Operating Grants
  • 资助金额:
    $55.73万
  • 财政年份:
    2019
  • 负责人:
    Lubell William D
  • 依托单位:
海外基金